Koizumi W - Search Results

1

Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancer.

Koizumi W, Tanabe S, Higuchi K, Sasaki T, Nakayama S, Nakatani K, Nishimura K, Shimoda T, Azuma M, Ishido K, Saigenji K. Koizumi W, et al. Anticancer Res. 2006 Sep-Oct;26(5B):3797-802. Anticancer Res. 2006. PMID: 17094404 Free article.

2

Advantages of Japanese response criteria for estimating the survival of patients with primary gastric cancer.

Koizumi W, Kurihara M, Tanabe S, Kondo I, Yamazaki I, Nonaka M, Shimamura Y, Saigenji K. Koizumi W, et al. Gastric Cancer. 1999 May;2(1):14-19. doi: 10.1007/s101200050015. Gastric Cancer. 1999. PMID: 11957065

3

A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.

Daigo S, Takahashi Y, Fujieda M, Ariyoshi N, Yamazaki H, Koizumi W, Tanabe S, Saigenji K, Nagayama S, Ikeda K, Nishioka Y, Kamataki T. Daigo S, et al. Among authors: koizumi w. Pharmacogenetics. 2002 Jun;12(4):299-306. doi: 10.1097/00008571-200206000-00005. Pharmacogenetics. 2002. PMID: 12042667

4

Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer.

Yamaguchi K, Tada M, Horikoshi N, Otani T, Takiuchi H, Saitoh S, Kanamaru R, Kasai Y, Koizumi W, Sakata Y, Taguchi T; Paclitaxel Gastric Cancer Study Group in Japan. Yamaguchi K, et al. Among authors: koizumi w. Gastric Cancer. 2002;5(2):90-5. doi: 10.1007/s101200200015. Gastric Cancer. 2002. PMID: 12111584 Clinical Trial.

5

Clinical outcome of endoscopic aspiration mucosectomy for early stage gastric cancer.

Tanabe S, Koizumi W, Mitomi H, Nakai H, Murakami S, Nagaba S, Kida M, Oida M, Saigenji K. Tanabe S, et al. Among authors: koizumi w. Gastrointest Endosc. 2002 Nov;56(5):708-13. doi: 10.1067/mge.2002.129085. Gastrointest Endosc. 2002. PMID: 12397280

6

Questionnaire for early detection of occult anemia.

Koizumi W, Saigenji K. Koizumi W, et al. Hepatogastroenterology. 2003 Jan-Feb;50(49):121-5. Hepatogastroenterology. 2003. PMID: 12630006

7

Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.

Koizumi W, Tanabe S, Imaizumi H, Hibi K, Kida M, Ohida M, Okayasu I, Saigenji K. Koizumi W, et al. Hepatogastroenterology. 2003 Jan-Feb;50(49):293-6. Hepatogastroenterology. 2003. PMID: 12630044

8

A pilot phase II study of capecitabine in advanced or recurrent gastric cancer.

Koizumi W, Saigenji K, Ujiie S, Terashima M, Sakata Y, Taguchi T; Clinical Study Group of Capecitabine. Koizumi W, et al. Oncology. 2003;64(3):232-6. doi: 10.1159/000069313. Oncology. 2003. PMID: 12697963 Clinical Trial.

9

Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.

Koizumi W, Tanabe S, Imaizumi H, Kida M, Ohida M, Koshida Y, Mitomi H, Hosaka Y, Nagaba S, Sasaki T, Higuchi K, Saigenji K. Koizumi W, et al. Hepatogastroenterology. 2003 Mar-Apr;50(50):577-81. Hepatogastroenterology. 2003. PMID: 12749277 Clinical Trial.

10

[Controversial issues in chemotherapy for inoperable gastric cancer].

Koizumi W, Tanabe S, Higuchi K, Sasaki T, Nakayama N, Nagaba S, Kitamura T, Azuma M, Saigenji K. Koizumi W, et al. Gan To Kagaku Ryoho. 2003 Sep;30(9):1249-55. Gan To Kagaku Ryoho. 2003. PMID: 14518402 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters